The American Heart Association is pumping almost 4-million dollars into the University of Washington, opening…
sciencecityJuly 10, 2019
OncoSenX, Inc., a late preclinical-stage company developing therapeutics to kill cancer cells based on their…
sciencecityJuly 9, 2019
James Heath, PhD., is president and professor at the Institute for Systems Biology in Seattle.…
sciencecityJuly 8, 2019
New findings show how a genetically aberrant, fused protein promotes a rare form of liver…
sciencecityJuly 5, 2019
Adaptive Biotechnologies’ first day as a public company is one for the record books. Shares…
sciencecityJuly 2, 2019
Mazyar Shadman, MD, MPH, assistant member, Fred Hutchinson Cancer Research Center, assistant professor, Medical Oncology…
sciencecityJuly 2, 2019
PATHWAYS TO DISCOVERY Looking east at the University of Washington Medical Center, where, over four…
sciencecityJuly 1, 2019
In the fall of 2012, while studying abroad at the University of Washington, Hao Shen…
sciencecityJune 28, 2019
BRI’s Matt Dufort, PhD, and Peter Linsley, PhD, led two new studies that could help…
sciencecityJune 27, 2019
